Molecular and immunological studies of MS Publications

  1. Andreassen S, Lindland EMS, Beyer MK, Solheim AM, Ljøstad U, Mygland Å, Lorentzen ÅR, Reiso H, Bjuland KJ, Pripp AH, Harbo HF, Løhaugen GCC, Eikeland R (2022)
    Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis
    J Neurol (in press)
    DOI 10.1007/s00415-022-11463-7, PubMed 36380166
  2. Cappelletti C, Eriksson A, Brorson IS, Leikfoss IS, Kråbøl O, Høgestøl EA, Vitelli V, Mjaavatten O, Harbo HF, Berven F, Bos SD, Berge T (2022)
    Quantitative proteomics reveals protein dysregulation during T cell activation in multiple sclerosis patients compared to healthy controls
    Clin Proteomics, 19 (1), 23
    DOI 10.1186/s12014-022-09361-1, PubMed 35790914
  3. Rise HH, Brune S, Chien C, Berge T, Bos SD, Andorrà M, Valdeolivas IP, Beyer MK, Sowa P, Scheel M, Brandt AU, Asseyer S, Blennow K, Pedersen ML, Zetterberg H, de Schotten MT, Cellerino M, Uccelli A, Paul F, Villoslada P, Harbo HF, Westlye LT, Høgestøl EA (2022)
    Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study
    Neuroimage Clin, 35, 103099
    DOI 10.1016/j.nicl.2022.103099, PubMed 35772194
  4. Lie IA, Wesnes K, Kvistad SS, Brouwer I, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Barkhof F, Vrenken H, Myhr KM, Bø L, Torkildsen Ø (2022)
    The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
    Neurol Neuroimmunol Neuroinflamm, 9 (5)
    DOI 10.1212/NXI.0000000000200008, PubMed 35738901
  5. Drobnjak Nes D, Berg-Hansen P, de Rodez Benavent SA, Høgestøl EA, Beyer MK, Rinker DA, Veiby N, Karabeg M, Petrovski BÉ, Celius EG, Harbo HF, Petrovski G (2022)
    Exploring Retinal Blood Vessel Diameters as Biomarkers in Multiple Sclerosis
    J Clin Med, 11 (11)
    DOI 10.3390/jcm11113109, PubMed 35683496
  6. Brune S, Høgestøl EA, de Rodez Benavent SA, Berg-Hansen P, Beyer MK, Leikfoss IS, Bos SD, Sowa P, Brunborg C, Andorra M, Pulido Valdeolivas I, Asseyer S, Brandt A, Chien C, Scheel M, Blennow K, Zetterberg H, Kerlero de Rosbo N, Paul F, Uccelli A, Villoslada P, Berge T, Harbo HF (2022)
    Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis
    Mult Scler, 28 (12), 1859-1870
    DOI 10.1177/13524585221097296, PubMed 35658739
  7. Lie IA, Kaçar S, Wesnes K, Brouwer I, Kvistad SS, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Varhaug KN, Vedeler CA, Barkhof F, Teunissen CE, Bø L, Torkildsen Ø, Myhr KM, Vrenken H (2022)
    Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study
    J Neurol Neurosurg Psychiatry, 93 (8), 849-57 (in press)
    DOI 10.1136/jnnp-2021-328568, PubMed 35649699
  8. Lindland ES, Solheim AM, Dareez MN, Eikeland R, Ljøstad U, Mygland Å, Reiso H, Lorentzen ÅR, Harbo HF, Beyer MK (2022)
    Enhancement of cranial nerves in Lyme neuroborreliosis: incidence and correlation with clinical symptoms and prognosis
    Neuroradiology, 64 (12), 2323-2333
    DOI 10.1007/s00234-022-02957-2, PubMed 35608630
  9. Andreassen S, Solheim AM, Ljøstad U, Mygland Å, Lorentzen ÅR, Reiso H, Beyer MK, Harbo HF, Løhaugen GCC, Eikeland R (2022)
    Cognitive function in patients with neuroborreliosis: A prospective cohort study from the acute phase to 12 months post treatment
    Brain Behav, 12 (6), e2608
    DOI 10.1002/brb3.2608, PubMed 35593485
  10. Leonardsen EH, Peng H, Kaufmann T, Agartz I, Andreassen OA, Celius EG, Espeseth T, Harbo HF, Høgestøl EA, Lange AM, Marquand AF, Vidal-Piñeiro D, Roe JM, Selbæk G, Sørensen Ø, Smith SM, Westlye LT, Wolfers T, Wang Y (2022)
    Deep neural networks learn general and clinically relevant representations of the ageing brain
    Neuroimage, 256, 119210
    DOI 10.1016/j.neuroimage.2022.119210, PubMed 35462035
  11. Brorson IS, Eriksson AM, Høgestøl E, Leikfoss IS, Harbo HF, Berge T, Vitelli V, Bos SD (2022)
    Global DNA methylation changes in treated and untreated MS patients measured over time
    J Neuroimmunol, 364, 577808
    DOI 10.1016/j.jneuroim.2022.577808, PubMed 35093762
  12. König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO (2021)
    Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations
    J Neurol Neurosurg Psychiatry
    DOI 10.1136/jnnp-2021-327612, PubMed 34670844
  13. Eriksson AM, Leikfoss IS, Abrahamsen G, Sundvold V, Isom MM, Keshari PK, Rognes T, Landsverk OJB, Bos SD, Harbo HF, Spurkland A, Berge T (2021)
    Exploring the role of the multiple sclerosis susceptibility gene CLEC16A in T cells
    Scand J Immunol, 94 (1), e13050
    DOI 10.1111/sji.13050, PubMed 34643957
  14. Høgestøl EA, Ghezzo S, Nygaard GO, Espeseth T, Sowa P, Beyer MK, Harbo HF, Westlye LT, Hulst HE, Alnæs D (2021)
    Functional connectivity in multiple sclerosis modelled as connectome stability: A 5-year follow-up study
    Mult Scler, 28 (4), 532-540
    DOI 10.1177/13524585211030212, PubMed 34259578
  15. Creary LE, Gangavarapu S, Caillier SJ, Cavalcante P, Frangiamore R, Lie BA, Bengtsson M, Harbo HF, Brauner S, Hollenbach JA, Oksenberg JR, Bernasconi P, Maniaol AH, Hammarström L, Mantegazza R, Fernández-Viña MA (2021)
    Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations
    Front Immunol, 12, 667336
    DOI 10.3389/fimmu.2021.667336, PubMed 34163474
  16. Aamodt AH, Høgestøl EA, Popperud TH, Holter JC, Dyrhol-Riise AM, Tonby K, Stiksrud B, Quist-Paulsen E, Berge T, Barratt-Due A, Aukrust P, Heggelund L, Blennow K, Zetterberg H, Harbo HF (2021)
    Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19
    J Neurol, 268 (10), 3574-3583
    DOI 10.1007/s00415-021-10517-6, PubMed 33743046
  17. Wesnes K, Myhr KM, Riise T, Kvistad SS, Torkildsen Ø, Wergeland S, Holmøy T, Midgard R, Bru A, Edland A, Eikeland R, Gosal S, Harbo HF, Kleveland G, Sørenes YS, Øksendal N, Bjørnevik K (2021)
    Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis
    Mult Scler Relat Disord, 50, 102801
    DOI 10.1016/j.msard.2021.102801, PubMed 33636616
  18. Andreassen S, Lindland EMS, Solheim AM, Beyer MK, Ljøstad U, Mygland Å, Lorentzen ÅR, Reiso H, Harbo HF, Løhaugen GCC, Eikeland R (2021)
    Cognitive function, fatigue and Fazekas score in patients with acute neuroborreliosis
    Ticks Tick Borne Dis, 12 (3), 101678
    DOI 10.1016/j.ttbdis.2021.101678, PubMed 33529985
  19. Brune S, Høgestøl EA, Cengija V, Berg-Hansen P, Sowa P, Nygaard GO, Harbo HF, Beyer MK (2020)
    LesionQuant for Assessment of MRI in Multiple Sclerosis-A Promising Supplement to the Visual Scan Inspection
    Front Neurol, 11, 546744
    DOI 10.3389/fneur.2020.546744, PubMed 33362682
  20. Brorson IS, Eriksson AM, Leikfoss IS, Vitelli V, Celius EG, Lüders T, Berge T, Harbo HF, Nilsen H, Bos SD (2020)
    CD8+ T cell gene expression analysis identifies differentially expressed genes between multiple sclerosis patients and healthy controls
    Mult Scler J Exp Transl Clin, 6 (4), 2055217320978511
    DOI 10.1177/2055217320978511, PubMed 33343920
  21. Elvsåshagen T, Bahrami S, van der Meer D, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Beyer MK, Blasi G, Borgwardt S, Boye B, Buitelaar J, Bøen E, Celius EG, Cervenka S, Conzelmann A, Coynel D, Di Carlo P, Djurovic S, Eisenacher S, Espeseth T, Fatouros-Bergman H, Flyckt L, Franke B et al. (2020)
    The genetic architecture of human brainstem structures and their involvement in common brain disorders
    Nat Commun, 11 (1), 4016
    DOI 10.1038/s41467-020-17376-1, PubMed 32782260
  22. Cellerino M, Ivaldi F, Pardini M, Rotta G, Vila G, Bäcker-Koduah P, Berge T, Laroni A, Lapucci C, Novi G, Boffa G, Sbragia E, Palmeri S, Asseyer S, Høgestøl E, Campi C, Piana M, Inglese M, Paul F, Harbo HF, Villoslada P, Kerlero de Rosbo N, Uccelli A (2020)
    Impact of treatment on cellular immunophenotype in MS: A cross-sectional study
    Neurol Neuroimmunol Neuroinflamm, 7 (3)
    DOI 10.1212/NXI.0000000000000693, PubMed 32139439
  23. Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Di Carlo P, Djurovic S, Dørum ES et al. (2020)
    Publisher Correction: Common brain disorders are associated with heritable patterns of apparent aging of the brain
    Nat Neurosci, 23 (2), 295
    DOI 10.1038/s41593-019-0553-6, PubMed 31848485
  24. Kaufmann T, van der Meer D, Doan NT, Schwarz E, Lund MJ, Agartz I, Alnæs D, Barch DM, Baur-Streubel R, Bertolino A, Bettella F, Beyer MK, Bøen E, Borgwardt S, Brandt CL, Buitelaar J, Celius EG, Cervenka S, Conzelmann A, Córdova-Palomera A, Dale AM, de Quervain DJF, Di Carlo P, Djurovic S, Dørum ES et al. (2019)
    Common brain disorders are associated with heritable patterns of apparent aging of the brain
    Nat Neurosci, 22 (10), 1617-1623
    DOI 10.1038/s41593-019-0471-7, PubMed 31551603
  25. Brorson IS, Eriksson A, Leikfoss IS, Celius EG, Berg-Hansen P, Barcellos LF, Berge T, Harbo HF, Bos SD (2019)
    No differential gene expression for CD4+ T cells of MS patients and healthy controls
    Mult Scler J Exp Transl Clin, 5 (2), 2055217319856903
    DOI 10.1177/2055217319856903, PubMed 31223483
  26. de Rodez Benavent SA, Nygaard GO, Nilsen KB, Etholm L, Sowa P, Wendel-Haga M, Harbo HF, Drolsum L, Laeng B, Kerty E, Celius EG (2019)
    Neurodegenerative Interplay of Cardiovascular Autonomic Dysregulation and the Retina in Early Multiple Sclerosis
    Front Neurol, 10, 507
    DOI 10.3389/fneur.2019.00507, PubMed 31156539
  27. Høgestøl EA, Kaufmann T, Nygaard GO, Beyer MK, Sowa P, Nordvik JE, Kolskår K, Richard G, Andreassen OA, Harbo HF, Westlye LT (2019)
    Cross-Sectional and Longitudinal MRI Brain Scans Reveal Accelerated Brain Aging in Multiple Sclerosis
    Front Neurol, 10, 450
    DOI 10.3389/fneur.2019.00450, PubMed 31114541
  28. Berge T, Eriksson A, Brorson IS, Høgestøl EA, Berg-Hansen P, Døskeland A, Mjaavatten O, Bos SD, Harbo HF, Berven F (2019)
    Quantitative proteomic analyses of CD4+ and CD8+ T cells reveal differentially expressed proteins in multiple sclerosis patients and healthy controls
    Clin Proteomics, 16, 19
    DOI 10.1186/s12014-019-9241-5, PubMed 31080378
  29. Høgestøl EA, Nygaard GO, Alnæs D, Beyer MK, Westlye LT, Harbo HF (2019)
    Symptoms of fatigue and depression is reflected in altered default mode network connectivity in multiple sclerosis
    PLoS One, 14 (4), e0210375
    DOI 10.1371/journal.pone.0210375, PubMed 30933977
  30. Rhead B, Brorson IS, Berge T, Adams C, Quach H, Moen SM, Berg-Hansen P, Celius EG, Sangurdekar DP, Bronson PG, Lea RA, Burnard S, Maltby VE, Scott RJ, Lechner-Scott J, Harbo HF, Bos SD, Barcellos LF (2018)
    Increased DNA methylation of SLFN12 in CD4+ and CD8+ T cells from multiple sclerosis patients
    PLoS One, 13 (10), e0206511
    DOI 10.1371/journal.pone.0206511, PubMed 30379917
  31. Page CM, Vos L, Rounge TB, Harbo HF, Andreassen BK (2018)
    Assessing genome-wide significance for the detection of differentially methylated regions
    Stat Appl Genet Mol Biol, 17 (5)
    DOI 10.1515/sagmb-2017-0050, PubMed 30231014
  32. Lindland ES, Solheim AM, Andreassen S, Quist-Paulsen E, Eikeland R, Ljøstad U, Mygland Å, Elsais A, Nygaard GO, Lorentzen ÅR, Harbo HF, Beyer MK (2018)
    Imaging in Lyme neuroborreliosis
    Insights Imaging, 9 (5), 833-844
    DOI 10.1007/s13244-018-0646-x, PubMed 30187265
  33. Kular L, Liu Y, Ruhrmann S, Zheleznyakova G, Marabita F, Gomez-Cabrero D, James T, Ewing E, Lindén M, Górnikiewicz B, Aeinehband S, Stridh P, Link J, Andlauer TFM, Gasperi C, Wiendl H, Zipp F, Gold R, Tackenberg B, Weber F, Hemmer B, Strauch K, Heilmann-Heimbach S, Rawal R, Schminke U et al. (2018)
    DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
    Nat Commun, 9 (1), 2397
    DOI 10.1038/s41467-018-04732-5, PubMed 29921915
  34. Sowa P, Harbo HF, White NS, Celius EG, Bartsch H, Berg-Hansen P, Moen SM, Bjørnerud A, Westlye LT, Andreassen OA, Dale AM, Beyer MK (2018)
    Restriction spectrum imaging of white matter and its relation to neurological disability in multiple sclerosis
    Mult Scler, 25 (5), 687-698
    DOI 10.1177/1352458518765671, PubMed 29542336
  35. Bajwa SK, Nilsen KB, Erichsen EAS, Berg-Hansen P, Harbo HF (2018)
    [A man in his 50s with dizziness, double vision and walking difficulties]
    Tidsskr Nor Laegeforen, 138 (3)
    DOI 10.4045/tidsskr.16.1109, PubMed 29411576
  36. Olafsson S, Stridh P, Bos SD, Ingason A, Euesden J, Sulem P, Thorleifsson G, Gustafsson O, Johannesson A, Geirsson AJ, Thorsson AV, Sigurgeirsson B, Ludviksson BR, Olafsson E, Kristjansdottir H, Jonasson JG, Olafsson JH, Orvar KB, Benediktsson R, Bjarnason R, Kristjansdottir S, Gislason T, Valdimarsson T, Mikaelsdottir E, Sigurdsson S et al. (2017)
    Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations
    NPJ Genom Med, 2, 24
    DOI 10.1038/s41525-017-0027-2, PubMed 29263835
  37. de Rodez Benavent SA, Nygaard GO, Harbo HF, Tønnesen S, Sowa P, Landrø NI, Wendel-Haga M, Etholm L, Nilsen KB, Drolsum L, Kerty E, Celius EG, Laeng B (2017)
    Fatigue and cognition: Pupillary responses to problem-solving in early multiple sclerosis patients
    Brain Behav, 7 (7), e00717
    DOI 10.1002/brb3.717, PubMed 28729927
  38. Gustavsen MW, Celius EG, Winsvold BS, Moen SM, Nygaard GO, Berg-Hansen P, Lie BA, Zwart JA, Harbo HF (2016)
    Migraine and frequent tension-type headache are not associated with multiple sclerosis in a Norwegian case-control study
    Mult Scler J Exp Transl Clin, 2, 2055217316682976
    DOI 10.1177/2055217316682976, PubMed 28607748
  39. Hedström AK, Katsoulis M, Hössjer O, Bomfim IL, Oturai A, Sondergaard HB, Sellebjerg F, Ullum H, Thørner LW, Gustavsen MW, Harbo HF, Obradovic D, Gianfrancesco MA, Barcellos LF, Schaefer CA, Hillert J, Kockum I, Olsson T, Alfredsson L (2017)
    The interaction between smoking and HLA genes in multiple sclerosis: replication and refinement
    Eur J Epidemiol, 32 (10), 909-919
    DOI 10.1007/s10654-017-0250-2, PubMed 28597127
  40. Sowa P, Nygaard GO, Bjørnerud A, Celius EG, Harbo HF, Beyer MK (2017)
    Magnetic resonance imaging perfusion is associated with disease severity and activity in multiple sclerosis
    Neuroradiology, 59 (7), 655-664
    DOI 10.1007/s00234-017-1849-4, PubMed 28585082
  41. Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK (2016)
    [Not Available]
    Tidsskr Nor Laegeforen, 136 (20), 1702
    DOI 10.4045/tidsskr.16.0865, PubMed 27830899
  42. Moen SM, Harbo HF, Celius EG, Sowa P, Nygaard GO, Beyer MK (2016)
    [Not Available]
    Tidsskr Nor Laegeforen, 136 (19), 1608
    DOI 10.4045/tidsskr.16.0826, PubMed 27790879
  43. Moen SM, Harbo HF, Sowa P, Celius EG, Nygaard GO, Beyer MK (2016)
    [MRI in multiple sclerosis]
    Tidsskr Nor Laegeforen, 136 (16), 1373-6
    DOI 10.4045/tidsskr.15.1361, PubMed 27637059
  44. George MF, Briggs FB, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedström A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, De Jager PL, Oturai AB, Søndergaard HB, Sellebjerg F, Sorensen PS, Gomez R, Caillier SJ, Cree BA, Oksenberg JR, Hauser SL et al. (2016)
    Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
    Neurol Genet, 2 (4), e87
    DOI 10.1212/NXG.0000000000000087, PubMed 27540591
  45. Keshari PK, Harbo HF, Myhr KM, Aarseth JH, Bos SD, Berge T (2016)
    Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood
    BMC Genet, 17, 59
    DOI 10.1186/s12863-016-0367-4, PubMed 27080863
  46. Keshavan A, Paul F, Beyer MK, Zhu AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, Fontaine B, Gaetano L, Goris A, Graetz C, Gröger A, Groppa S, Hafler DA et al. (2016)
    Power estimation for non-standardized multisite studies
    Neuroimage, 134, 281-294
    DOI 10.1016/j.neuroimage.2016.03.051, PubMed 27039700
  47. Bos SD, Berge T, Celius EG, Harbo HF (2016)
    From genetic associations to functional studies in multiple sclerosis
    Eur J Neurol, 23 (5), 847-53
    DOI 10.1111/ene.12981, PubMed 26948534
  48. Wang Y, Bos SD, Harbo HF, Thompson WK, Schork AJ, Bettella F, Witoelar A, Lie BA, Li W, McEvoy LK, Djurovic S, Desikan RS, Dale AM, Andreassen OA (2016)
    Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors
    Mult Scler, 22 (14), 1783-1793
    DOI 10.1177/1352458516635873, PubMed 26920376
  49. Berge T, Leikfoss IS, Brorson IS, Bos SD, Page CM, Gustavsen MW, Bjølgerud A, Holmøy T, Celius EG, Damoiseaux J, Smolders J, Harbo HF, Spurkland A (2016)
    The multiple sclerosis susceptibility genes TAGAP and IL2RA are regulated by vitamin D in CD4+ T cells
    Genes Immun, 17 (2), 118-27
    DOI 10.1038/gene.2015.61, PubMed 26765264
  50. Nygaard GO, de Rodez Benavent SA, Harbo HF, Laeng B, Sowa P, Damangir S, Bernhard Nilsen K, Etholm L, Tønnesen S, Kerty E, Drolsum L, Inge Landrø N, Celius EG (2015)
    Eye and hand motor interactions with the Symbol Digit Modalities Test in early multiple sclerosis
    Mult Scler Relat Disord, 4 (6), 585-9
    DOI 10.1016/j.msard.2015.08.003, PubMed 26590666
  51. Seldin MF, Alkhairy OK, Lee AT, Lamb JA, Sussman J, Pirskanen-Matell R, Piehl F, Verschuuren JJGM, Kostera-Pruszczyk A, Szczudlik P, McKee D, Maniaol AH, Harbo HF, Lie BA, Melms A, Garchon HJ, Willcox N, Gregersen PK, Hammarstrom L (2015)
    Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations
    Mol Med, 21 (1), 769-781
    DOI 10.2119/molmed.2015.00232, PubMed 26562150
  52. Page CM, Baranzini SE, Mevik BH, Bos SD, Harbo HF, Andreassen BK (2015)
    Assessing the Power of Exome Chips
    PLoS One, 10 (10), e0139642
    DOI 10.1371/journal.pone.0139642, PubMed 26437075
  53. Berg-Hansen P, Moen SM, Harbo HF, Celius EG (2015)
    Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'
    Acta Neurol Scand, 132 (5), 364-7
    DOI 10.1111/ane.12489, PubMed 26423981
  54. Sowa P, Bjørnerud A, Nygaard GO, Damangir S, Spulber G, Celius EG, Due-Tønnessen P, Harbo HF, Beyer MK (2015)
    Reduced perfusion in white matter lesions in multiple sclerosis
    Eur J Radiol, 84 (12), 2605-12
    DOI 10.1016/j.ejrad.2015.09.007, PubMed 26391230
  55. Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TMC, Booth D, Buck D, Celius EG, Cotsapas C, D'Alfonso S, Dendrou CA, Donnelly P, Dubois B, Fontaine B, Fugger L, Goris A et al. (2015)
    Class II HLA interactions modulate genetic risk for multiple sclerosis
    Nat Genet, 47 (10), 1107-1113
    DOI 10.1038/ng.3395, PubMed 26343388
  56. Wedding IM, Kroken M, Henriksen SP, Selmer KK, Fiskerstrand T, Knappskog PM, Berge T, Tallaksen CM (2015)
    Friedreich ataxia in Norway - an epidemiological, molecular and clinical study
    Orphanet J Rare Dis, 10, 108
    DOI 10.1186/s13023-015-0328-4, PubMed 26338206
  57. Nygaard GO, Celius EG, de Rodez Benavent SA, Sowa P, Gustavsen MW, Fjell AM, Landrø NI, Walhovd KB, Harbo HF (2015)
    A Longitudinal Study of Disability, Cognition and Gray Matter Atrophy in Early Multiple Sclerosis Patients According to Evidence of Disease Activity
    PLoS One, 10 (8), e0135974
    DOI 10.1371/journal.pone.0135974, PubMed 26280173
  58. Leikfoss IS, Keshari PK, Gustavsen MW, Bjølgerud A, Brorson IS, Celius EG, Spurkland A, Bos SD, Harbo HF, Berge T (2015)
    Multiple Sclerosis Risk Allele in CLEC16A Acts as an Expression Quantitative Trait Locus for CLEC16A and SOCS1 in CD4+ T Cells
    PLoS One, 10 (7), e0132957
    DOI 10.1371/journal.pone.0132957, PubMed 26203907
  59. Bos SD, Page CM, Andreassen BK, Elboudwarej E, Gustavsen MW, Briggs F, Quach H, Leikfoss IS, Bjølgerud A, Berge T, Harbo HF, Barcellos LF (2015)
    Genome-wide DNA methylation profiles indicate CD8+ T cell hypermethylation in multiple sclerosis
    PLoS One, 10 (3), e0117403
    DOI 10.1371/journal.pone.0117403, PubMed 25734800
  60. Goris A, Pauwels I, Gustavsen MW, van Son B, Hilven K, Bos SD, Celius EG, Berg-Hansen P, Aarseth J, Myhr KM, D'Alfonso S, Barizzone N, Leone MA, Martinelli Boneschi F, Sorosina M, Liberatore G, Kockum I, Olsson T, Hillert J, Alfredsson L, Bedri SK, Hemmer B, Buck D, Berthele A, Knier B et al. (2015)
    Genetic variants are major determinants of CSF antibody levels in multiple sclerosis
    Brain, 138 (Pt 3), 632-43
    DOI 10.1093/brain/awu405, PubMed 25616667
  61. Eriksen AB, Berge T, Gustavsen MW, Leikfoss IS, Bos SD, Spurkland A, Harbo HF, Blomhoff HK (2014)
    Retinoic acid enhances the levels of IL-10 in TLR-stimulated B cells from patients with relapsing-remitting multiple sclerosis
    J Neuroimmunol, 278, 11-8
    DOI 10.1016/j.jneuroim.2014.11.019, PubMed 25595247
  62. Granum S, Sundvold-Gjerstad V, Gopalakrishnan RP, Berge T, Koll L, Abrahamsen G, Sørlie M, Spurkland A (2014)
    The kinase Itk and the adaptor TSAd change the specificity of the kinase Lck in T cells by promoting the phosphorylation of Tyr192
    Sci Signal, 7 (355), ra118
    DOI 10.1126/scisignal.2005384, PubMed 25492967
  63. Avidan N, Le Panse R, Harbo HF, Bernasconi P, Poulas K, Ginzburg E, Cavalcante P, Colleoni L, Baggi F, Antozzi C, Truffault F, Horn-Saban S, Pöschel S, Zagoriti Z, Maniaol A, Lie BA, Bernard I, Saoudi A, Illes Z, Casasnovas Pons C, Melms A, Tzartos S, Willcox N, Kostera-Pruszczyk A, Tallaksen C et al. (2014)
    VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravis
    Ann Clin Transl Neurol, 1 (5), 329-39
    DOI 10.1002/acn3.51, PubMed 25356403
  64. Berg-Hansen P, Moen SM, Sandvik L, Harbo HF, Bakken IJ, Stoltenberg C, Celius EG (2014)
    Prevalence of multiple sclerosis among immigrants in Norway
    Mult Scler, 21 (6), 695-702
    DOI 10.1177/1352458514554055, PubMed 25344371
  65. Sundal C, Baker M, Karrenbauer V, Gustavsen M, Bedri S, Glaser A, Myhr KM, Haugarvoll K, Zetterberg H, Harbo H, Kockum I, Hillert J, Wszolek Z, Rademakers R, Andersen O (2014)
    Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis
    Eur J Neurol, 22 (2), 328-333
    DOI 10.1111/ene.12572, PubMed 25311247
  66. Gustavsen MW, Page CM, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Celius EG, Harbo HF (2014)
    Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study
    BMC Neurol, 14, 196
    DOI 10.1186/s12883-014-0196-x, PubMed 25274070
  67. Westerlind H, Imrell K, Ramanujam R, Myhr KM, Celius EG, Harbo HF, Oturai AB, Hamsten A, Alfredsson L, Olsson T, Kockum I, Koski T, Hillert J (2014)
    Identity-by-descent mapping in a Scandinavian multiple sclerosis cohort
    Eur J Hum Genet, 23 (5), 688-92
    DOI 10.1038/ejhg.2014.155, PubMed 25159868
  68. Nygaard GO, Walhovd KB, Sowa P, Chepkoech JL, Bjørnerud A, Due-Tønnessen P, Landrø NI, Damangir S, Spulber G, Storsve AB, Beyer MK, Fjell AM, Celius EG, Harbo HF (2014)
    Cortical thickness and surface area relate to specific symptoms in early relapsing-remitting multiple sclerosis
    Mult Scler, 21 (4), 402-14
    DOI 10.1177/1352458514543811, PubMed 25139946
  69. Gustavsen MW, Celius EG, Moen SM, Bjølgerud A, Berg-Hansen P, Nygaard GO, Sandvik L, Lie BA, Harbo HF (2014)
    No association between multiple sclerosis and periodontitis after adjusting for smoking habits
    Eur J Neurol, 22 (3), 588-90
    DOI 10.1111/ene.12520, PubMed 25041906
  70. Gustavsen MW, Viken MK, Celius EG, Berge T, Mero IL, Berg-Hansen P, Aarseth JH, Myhr KM, Søndergaard HB, Sellebjerg F, Oturai AB, Hillert J, Alfredsson L, Olsson T, Kockum I, Lie BA, Harbo HF (2014)
    Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general
    J Neuroimmunol, 274 (1-2), 174-9
    DOI 10.1016/j.jneuroim.2014.06.024, PubMed 25037176
  71. Berg-Hansen P, Moen SM, Harbo HF, Celius EG (2014)
    High prevalence and no latitude gradient of multiple sclerosis in Norway
    Mult Scler, 20 (13), 1780-2
    DOI 10.1177/1352458514525871, PubMed 24603884
  72. Andreassen OA, Harbo HF, Wang Y, Thompson WK, Schork AJ, Mattingsdal M, Zuber V, Bettella F, Ripke S, Kelsoe JR, Kendler KS, O'Donovan MC, Sklar P, Psychiatric Genomics Consortium (PGC) Bipolar Disorder and Schizophrenia Work Groups, International Multiple Sclerosis Genetics Consortium (IMSGC), McEvoy LK, Desikan RS, Lie BA, Djurovic S, Dale AM (2014)
    Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci
    Mol Psychiatry, 20 (2), 207-14
    DOI 10.1038/mp.2013.195, PubMed 24468824
  73. Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA (2013)
    Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis
    Mult Scler, 20 (6), 660-8
    DOI 10.1177/1352458513506503, PubMed 24099750
  74. International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, Fontaine B, Hemmer B, Martin C, Zipp F, D'Alfonso S, Martinelli-Boneschi F, Taylor B, Harbo HF, Kockum I, Hillert J, Olsson T, Ban M et al. (2013)
    Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
    Nat Genet, 45 (11), 1353-60
    DOI 10.1038/ng.2770, PubMed 24076602
  75. Harbo HF, Gold R, Tintoré M (2013)
    Sex and gender issues in multiple sclerosis
    Ther Adv Neurol Disord, 6 (4), 237-48
    DOI 10.1177/1756285613488434, PubMed 23858327
  76. Berg-Hansen P, Smestad C, Sandvik L, Harbo HF, Celius EG (2013)
    Increased disease severity in non-Western immigrants with multiple sclerosis in Oslo, Norway
    Eur J Neurol, 20 (12), 1546-52
    DOI 10.1111/ene.12227, PubMed 23834430
  77. Leone MA, Barizzone N, Esposito F, Lucenti A, Harbo HF, Goris A, Kockum I, Oturai AB, Celius EG, Mero IL, Dubois B, Olsson T, Søndergaard HB, Cusi D, Lupoli S, Andreassen BK, International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Myhr KM, Guerini FR, PROGEMUS Group, PROGRESSO Group, Comi G, Martinelli-Boneschi F, D'Alfonso S (2013)
    Association of genetic markers with CSF oligoclonal bands in multiple sclerosis patients
    PLoS One, 8 (6), e64408
    DOI 10.1371/journal.pone.0064408, PubMed 23785401
  78. Isobe N, Gourraud PA, Harbo HF, Caillier SJ, Santaniello A, Khankhanian P, Maiers M, Spellman S, Cereb N, Yang S, Pando MJ, Piccio L, Cross AH, De Jager PL, Cree BA, Hauser SL, Oksenberg JR (2013)
    Genetic risk variants in African Americans with multiple sclerosis
    Neurology, 81 (3), 219-27
    DOI 10.1212/WNL.0b013e31829bfe2f, PubMed 23771490
  79. Høglund RA, Holmøy T, Harbo HF, Maghazachi AA (2013)
    A one year follow-up study of natural killer and dendritic cells activities in multiple sclerosis patients receiving glatiramer acetate (GA)
    PLoS One, 8 (4), e62237
    DOI 10.1371/journal.pone.0062237, PubMed 23614042
  80. Mero IL, Gustavsen MW, Sæther HS, Flåm ST, Berg-Hansen P, Søndergaard HB, Jensen PE, Berge T, Bjølgerud A, Muggerud A, Aarseth JH, International Multiple Sclerosis Genetics Consortium, Myhr KM, Celius EG, Sellebjerg F, Hillert J, Alfredsson L, Olsson T, Oturai AB, Kockum I, Lie BA, Andreassen BK, Harbo HF (2013)
    Oligoclonal band status in Scandinavian multiple sclerosis patients is associated with specific genetic risk alleles
    PLoS One, 8 (3), e58352
    DOI 10.1371/journal.pone.0058352, PubMed 23472185
  81. Ban M, Caillier S, Mero IL, Myhr KM, Celius EG, Aarseth J, Torkildsen Ø, Harbo HF, Oksenberg J, Hauser SL, Sawcer S, Compston A (2013)
    No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis
    Ann Neurol, 73 (3), 430-2
    DOI 10.1002/ana.23833, PubMed 23444327
  82. Berge T, Leikfoss IS, Harbo HF (2013)
    From Identification to Characterization of the Multiple Sclerosis Susceptibility Gene CLEC16A
    Int J Mol Sci, 14 (3), 4476-97
    DOI 10.3390/ijms14034476, PubMed 23439554
  83. Harbo HF, Mero IL (2012)
    From genes to characteristics of multiple sclerosis
    Acta Neurol Scand Suppl (195), 76-83
    DOI 10.1111/ane.12027, PubMed 23278661
  84. Leikfoss IS, Mero IL, Dahle MK, Lie BA, Harbo HF, Spurkland A, Berge T (2012)
    Multiple sclerosis-associated single-nucleotide polymorphisms in CLEC16A correlate with reduced SOCS1 and DEXI expression in the thymus
    Genes Immun, 14 (1), 62-6
    DOI 10.1038/gene.2012.52, PubMed 23151489
  85. Berge T, Grønningsæter IH, Lorvik KB, Abrahamsen G, Granum S, Sundvold-Gjerstad V, Corthay A, Bogen B, Spurkland A (2012)
    SH2D2A modulates T cell mediated protection to a B cell derived tumor in transgenic mice
    PLoS One, 7 (10), e48239
    DOI 10.1371/journal.pone.0048239, PubMed 23144743
  86. Brambilla P, Esposito F, Lindstrom E, Sorosina M, Giacalone G, Clarelli F, Rodegher M, Colombo B, Moiola L, Ghezzi A, Capra R, Collimedaglia L, Coniglio G, Celius EG, Galimberti D, Sørensen PS, Martinelli V, Oturai AB, Harbo HF, Hillert J, Comi G, Martinelli-Boneschi F (2012)
    Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans
    Neurosci Lett, 530 (2), 155-60
    DOI 10.1016/j.neulet.2012.10.008, PubMed 23069673
  87. Gregersen PK, Kosoy R, Lee AT, Lamb J, Sussman J, McKee D, Simpfendorfer KR, Pirskanen-Matell R, Piehl F, Pan-Hammarstrom Q, Verschuuren JJ, Titulaer MJ, Niks EH, Marx A, Ströbel P, Tackenberg B, Pütz M, Maniaol A, Elsais A, Tallaksen C, Harbo HF, Lie BA, Raychaudhuri S, de Bakker PI, Melms A et al. (2012)
    Risk for myasthenia gravis maps to a (151) Pro→Ala change in TNIP1 and to human leukocyte antigen-B*08
    Ann Neurol, 72 (6), 927-35
    DOI 10.1002/ana.23691, PubMed 23055271
  88. Maniaol AH, Boldingh M, Brunborg C, Harbo HF, Tallaksen CME (2012)
    Smoking and socio-economic status may affect myasthenia gravis
    Eur J Neurol, 20 (3), 453-460
    DOI 10.1111/j.1468-1331.2012.03843.x, PubMed 22934661
  89. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE (2012)
    The genetics of multiple sclerosis: an up-to-date review
    Immunol Rev, 248 (1), 87-103
    DOI 10.1111/j.1600-065X.2012.01134.x, PubMed 22725956
  90. Maniaol AH, Elsais A, Lorentzen ÅR, Owe JF, Viken MK, Sæther H, Flåm ST, Bråthen G, Kampman MT, Midgard R, Christensen M, Rognerud A, Kerty E, Gilhus NE, Tallaksen CM, Lie BA, Harbo HF (2012)
    Late onset myasthenia gravis is associated with HLA DRB1*15:01 in the Norwegian population
    PLoS One, 7 (5), e36603
    DOI 10.1371/journal.pone.0036603, PubMed 22590574
  91. Link J, Kockum I, Lorentzen AR, Lie BA, Celius EG, Westerlind H, Schaffer M, Alfredsson L, Olsson T, Brynedal B, Harbo HF, Hillert J (2012)
    Importance of human leukocyte antigen (HLA) class I and II alleles on the risk of multiple sclerosis
    PLoS One, 7 (5), e36779
    DOI 10.1371/journal.pone.0036779, PubMed 22586495
  92. Martinelli-Boneschi F, Esposito F, Brambilla P, Lindström E, Lavorgna G, Stankovich J, Rodegher M, Capra R, Ghezzi A, Coniglio G, Colombo B, Sorosina M, Martinelli V, Booth D, Oturai AB, Stewart G, Harbo HF, Kilpatrick TJ, Hillert J, Rubio JP, Abderrahim H, Wojcik J, Comi G (2012)
    A genome-wide association study in progressive multiple sclerosis
    Mult Scler, 18 (10), 1384-94
    DOI 10.1177/1352458512439118, PubMed 22457343
  93. Mero IL, Smestad C, Lie BA, Lorentzen ÅR, Sandvik L, Landrø NI, Aarseth JH, Myhr KM, Celius EG, Harbo HF (2012)
    Polymorphisms of the BDNF gene show neither association with multiple sclerosis susceptibility nor clinical course
    J Neuroimmunol, 244 (1-2), 107-10
    DOI 10.1016/j.jneuroim.2012.01.011, PubMed 22341604
  94. Harbo HF, Lorentzen AR, Lie BA, Celius EG, Spurkland A (2011)
    [New gene map for multiple sclerosis]
    Tidsskr Nor Laegeforen, 131 (21), 2126-30
    DOI 10.4045/tidsskr.10.0823, PubMed 22048209
  95. Pandya AD, Al-Jaderi Z, Høglund RA, Holmøy T, Harbo HF, Norgauer J, Maghazachi AA (2011)
    Identification of human NK17/NK1 cells
    PLoS One, 6 (10), e26780
    DOI 10.1371/journal.pone.0026780, PubMed 22039549
  96. Hansen B, Oturai AB, Harbo HF, Celius EG, Nissen KK, Laska MJ, Søndergaard HB, Petersen T, Nexø BA (2011)
    Genetic association of multiple sclerosis with the marker rs391745 near the endogenous retroviral locus HERV-Fc1: analysis of disease subtypes
    PLoS One, 6 (10), e26438
    DOI 10.1371/journal.pone.0026438, PubMed 22039488
  97. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C, Hunt SE, Edkins S, Gray E, Booth DR, Potter SC, Goris A, Band G, Oturai AB, Strange A, Saarela J, Bellenguez C, Fontaine B, Gillman M, Hemmer B et al. (2011)
    Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
    Nature, 476 (7359), 214-9
    DOI 10.1038/nature10251, PubMed 21833088
  98. Lundström W, Greiner E, Lundmark F, Westerlind H, Smestad C, Lorentzen AR, Kockum I, Link J, Brynedal B, Celius EG, Harbo HF, Masterman T, Hillert J (2011)
    No influence on disease progression of non-HLA susceptibility genes in MS
    J Neuroimmunol, 237 (1-2), 98-100
    DOI 10.1016/j.jneuroim.2011.05.003, PubMed 21742385
  99. Søndergaard HB, Sellebjerg F, Hillert J, Olsson T, Kockum I, Lindén M, Mero IL, Myhr KM, Celius EG, Harbo HF, Christensen JR, Börnsen L, Sørensen PS, Oturai AB (2011)
    Alterations in KLRB1 gene expression and a Scandinavian multiple sclerosis association study of the KLRB1 SNP rs4763655
    Eur J Hum Genet, 19 (10), 1100-3
    DOI 10.1038/ejhg.2011.88, PubMed 21610746
  100. Mero IL, Ban M, Lorentzen ÅR, Smestad C, Celius EG, Sæther H, Saeedi H, Viken MK, Skinningsrud B, Undlien DE, Aarseth J, Myhr KM, Granum S, Spurkland A, Sawcer S, Compston A, Lie BA, Harbo HF (2010)
    Exploring the CLEC16A gene reveals a MS-associated variant with correlation to the relative expression of CLEC16A isoforms in thymus
    Genes Immun, 12 (3), 191-8
    DOI 10.1038/gene.2010.59, PubMed 21179112
  101. Beyeen AD, Adzemovic MZ, Ockinger J, Stridh P, Becanovic K, Laaksonen H, Lassmann H, Harris RA, Hillert J, Alfredsson L, Celius EG, Harbo HF, Kockum I, Jagodic M, Olsson T (2010)
    IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation
    J Immunol, 185 (11), 6883-90
    DOI 10.4049/jimmunol.1001392, PubMed 21041731
  102. Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF (2010)
    Association to the Glypican-5 gene in multiple sclerosis
    J Neuroimmunol, 226 (1-2), 194-7
    DOI 10.1016/j.jneuroim.2010.07.003, PubMed 20692050
  103. Link J, Lorentzen AR, Kockum I, Duvefelt K, Lie BA, Celius EG, Harbo HF, Hillert J, Brynedal B (2010)
    Two HLA class I genes independently associated with multiple sclerosis
    J Neuroimmunol, 226 (1-2), 172-6
    DOI 10.1016/j.jneuroim.2010.07.006, PubMed 20678810
  104. International Multiple Sclerosis Genetics Consortium (IMSGC), Booth DR, Heard RN, Stewart GJ, Cox M, Scott RJ, Lechner-Scott J, Goris A, Dobosi R, Dubois B, Saarela J, Leppä V, Peltonen L, Pirttila T, Cournu-Rebeix I, Fontaine B, Bergamaschi L, D'Alfonso S, Leone M, Lorentzen AR, Harbo HF, Celius EG, Spurkland A, Link J, Kockum I et al. (2010)
    Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis
    Nat Genet, 42 (6), 469-70; author reply 470-1
    DOI 10.1038/ng0610-469, PubMed 20502484
  105. Burgunder JM, Schöls L, Baets J, Andersen P, Gasser T, Szolnoki Z, Fontaine B, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Finsterer J (2011)
    EFNS guidelines for the molecular diagnosis of neurogenetic disorders: motoneuron, peripheral nerve and muscle disorders
    Eur J Neurol, 18 (2), 207-217
    DOI 10.1111/j.1468-1331.2010.03069.x, PubMed 20500522
  106. Kolltveit KM, Schreurs O, Ostrem J, Søland TM, Khuu C, Berge T, Messelt E, Hayashi K, Granum S, Spurkland A, Schenck K (2010)
    Expression of the T-cell-specific adapter protein in oral epithelium
    Eur J Oral Sci, 118 (2), 159-67
    DOI 10.1111/j.1600-0722.2010.00719.x, PubMed 20487005
  107. Holmøy T, Harbo HF, Celius EG (2010)
    [Treatment of multiple sclerosis]
    Tidsskr Nor Laegeforen, 130 (9), 923; author reply 923
    DOI 10.4045/tidsskr.10.0346, PubMed 20453948
  108. Jagodic M, Colacios C, Nohra R, Dejean AS, Beyeen AD, Khademi M, Casemayou A, Lamouroux L, Duthoit C, Papapietro O, Sjöholm L, Bernard I, Lagrange D, Dahlman I, Lundmark F, Oturai AB, Soendergaard HB, Kemppinen A, Saarela J, Tienari PJ, Harbo HF, Spurkland A, Ramagopalan SV, Sadovnick DA, Ebers GC et al. (2009)
    A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis
    Sci Transl Med, 1 (10), 10ra21
    DOI 10.1126/scitranslmed.3000278, PubMed 20368159
  109. Berge T, Sundvold-Gjerstad V, Granum S, Andersen TC, Holthe GB, Claesson-Welsh L, Andreotti AH, Inngjerdingen M, Spurkland A (2010)
    T cell specific adapter protein (TSAd) interacts with Tec kinase ITK to promote CXCL12 induced migration of human and murine T cells
    PLoS One, 5 (3), e9761
    DOI 10.1371/journal.pone.0009761, PubMed 20305788
  110. Burgunder JM, Finsterer J, Szolnoki Z, Fontaine B, Baets J, Van Broeckhoven C, Di Donato S, De Jonghe P, Lynch T, Mariotti C, Schöls L, Spinazzola A, Tabrizi SJ, Tallaksen C, Zeviani M, Harbo HF, Gasser T, EFNS (2010)
    EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementias
    Eur J Neurol, 17 (5), 641-8
    DOI 10.1111/j.1468-1331.2010.02985.x, PubMed 20298421
  111. Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A, Purcell S, Koivisto K, Tienari P, Sumelahti ML, Elovaara I, Pirttilä T, Reunanen M, Aromaa A, Oturai AB, Søndergaard HB, Harbo HF, Mero IL, Gabriel SB, Mirel DB, Hauser SL, Kappos L, Polman C, De Jager PL, Hafler DA et al. (2010)
    Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene
    Am J Hum Genet, 86 (2), 285-91
    DOI 10.1016/j.ajhg.2010.01.017, PubMed 20159113
  112. Nohra R, Beyeen AD, Guo JP, Khademi M, Sundqvist E, Hedreul MT, Sellebjerg F, Smestad C, Oturai AB, Harbo HF, Wallström E, Hillert J, Alfredsson L, Kockum I, Jagodic M, Lorentzen J, Olsson T (2010)
    RGMA and IL21R show association with experimental inflammation and multiple sclerosis
    Genes Immun, 11 (4), 279-93
    DOI 10.1038/gene.2009.111, PubMed 20072140
  113. Gasser T, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, Zeviani M, Burgunder JM, Harbo HF, EFNS (2009)
    EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias
    Eur J Neurol, 17 (2), 179-88
    DOI 10.1111/j.1468-1331.2009.02873.x, PubMed 20050888
  114. Harbo HF, Riccio ME, Lorentzen AR, Utsi E, Myhr KM, Mellgren SI, Flåm ST, Thorsby E, Sanchez-Mazas A, Lie BA (2009)
    Norwegian Sami differs significantly from other Norwegians according to their HLA profile
    Tissue Antigens, 75 (3), 207-17
    DOI 10.1111/j.1399-0039.2009.01425.x, PubMed 20047643
  115. Ramagopalan SV, Link J, Byrnes JK, Dyment DA, Giovannoni G, Hintzen RQ, Sundqvist E, Kockum I, Smestad C, Lie BA, Harbo HF, Padyukov L, Alfredsson L, Olsson T, Sadovnick AD, Hillert J, Ebers GC (2009)
    HLA-DRB1 and month of birth in multiple sclerosis
    Neurology, 73 (24), 2107-11
    DOI 10.1212/WNL.0b013e3181c679f3, PubMed 20018638
  116. Finsterer J, Harbo HF, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen CM, Zeviani M, Burgunder JM, Gasser T, European Federation of Neurological Sciences (2009)
    EFNS guidelines on the molecular diagnosis of mitochondrial disorders
    Eur J Neurol, 16 (12), 1255-64
    DOI 10.1111/j.1468-1331.2009.02811.x, PubMed 19950421
  117. Mero IL, Lorentzen AR, Ban M, Smestad C, Celius EG, Aarseth JH, Myhr KM, Link J, Hillert J, Olsson T, Kockum I, Masterman T, Oturai AB, Søndergaard HB, Sellebjerg F, Saarela J, Kemppinen A, Elovaara I, Spurkland A, Dudbridge F, Lie BA, Harbo HF (2009)
    A rare variant of the TYK2 gene is confirmed to be associated with multiple sclerosis
    Eur J Hum Genet, 18 (4), 502-4
    DOI 10.1038/ejhg.2009.195, PubMed 19888296
  118. Lorentzen AR, Karlsen TH, Olsson M, Smestad C, Mero IL, Woldseth B, Sun JY, Senitzer D, Celius EG, Thorsby E, Spurkland A, Lie BA, Harbo HF (2009)
    Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis
    Ann Neurol, 65 (6), 658-66
    DOI 10.1002/ana.21695, PubMed 19630074
  119. Holmøy T, Harbo H, Vartdal F, Spurkland A (2009)
    Genetic and molecular approaches to the immunopathogenesis of multiple sclerosis: an update
    Curr Mol Med, 9 (5), 591-611
    DOI 10.2174/156652409788488793, PubMed 19601809
  120. Harbo HF, Finsterer J, Baets J, Van Broeckhoven C, Di Donato S, Fontaine B, De Jonghe P, Lossos A, Lynch T, Mariotti C, Schöls L, Spinazzola A, Szolnoki Z, Tabrizi SJ, Tallaksen C, Zeviani M, Burgunder JM, Gasser T, EFNS (2009)
    EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystonias
    Eur J Neurol, 16 (7), 777-85
    DOI 10.1111/j.1468-1331.2009.02646.x, PubMed 19469830
  121. Ban M, Goris A, Lorentzen AR, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart GJ, Bogaert E, Dubois B, Harbo HF, Celius EG, Spurkland A, Strange R, Hawkins C, Robertson NP, Dudbridge F, Wason J, De Jager PL, Hafler D, Rioux JD, Ivinson AJ, McCauley JL, Pericak-Vance M et al. (2009)
    Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor
    Eur J Hum Genet, 17 (10), 1309-13
    DOI 10.1038/ejhg.2009.41, PubMed 19293837
  122. Kallio SP, Jakkula E, Purcell S, Suvela M, Koivisto K, Tienari PJ, Elovaara I, Pirttilä T, Reunanen M, Bronnikov D, Viander M, Meri S, Hillert J, Lundmark F, Harbo HF, Lorentzen AR, De Jager PL, Daly MJ, Hafler DA, Palotie A, Peltonen L, Saarela J (2009)
    Use of a genetic isolate to identify rare disease variants: C7 on 5p associated with MS
    Hum Mol Genet, 18 (9), 1670-83
    DOI 10.1093/hmg/ddp073, PubMed 19221116
  123. Kemppinen A, Suvela M, Tienari PJ, Elovaara I, Koivisto K, Pirttilä T, Reunanen M, Rautakorpi I, Hillert J, Lundmark F, Oturai A, Ryder L, Harbo HF, Celius EG, Palotie A, Daly M, Peltonen L, Saarela J (2009)
    MYO9B polymorphisms in multiple sclerosis
    Eur J Hum Genet, 17 (6), 840-3
    DOI 10.1038/ejhg.2008.251, PubMed 19142207
  124. Lorentzen AR, Smestad C, Lie BA, Oturai AB, Akesson E, Saarela J, Myhr KM, Vartdal F, Celius EG, Sørensen PS, Hillert J, Spurkland A, Harbo HF (2008)
    The SH2D2A gene and susceptibility to multiple sclerosis
    J Neuroimmunol, 197 (2), 152-8
    DOI 10.1016/j.jneuroim.2008.04.037, PubMed 18554728
  125. Granum S, Andersen TC, Sørlie M, Jørgensen M, Koll L, Berge T, Lea T, Fleckenstein B, Spurkland A, Sundvold-Gjerstad V (2008)
    Modulation of Lck function through multisite docking to T cell-specific adapter protein
    J Biol Chem, 283 (32), 21909-19
    DOI 10.1074/jbc.M800871200, PubMed 18541536
  126. Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, Riise T, Wolfson C (2008)
    Environmental risk factors in multiple sclerosis
    Acta Neurol Scand Suppl, 188, 34-40
    DOI 10.1111/j.1600-0404.2008.01029.x, PubMed 18439219
  127. Smestad C, Sandvik L, Holmoy T, Harbo HF, Celius EG (2007)
    Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway
    J Neurol, 255 (1), 49-55
    DOI 10.1007/s00415-007-0659-8, PubMed 18080855
  128. Knudsen GP, Harbo HF, Smestad C, Celius EG, Akesson E, Oturai A, Ryder LP, Spurkland A, Ørstavik KH (2007)
    X chromosome inactivation in females with multiple sclerosis
    Eur J Neurol, 14 (12), 1392-6
    DOI 10.1111/j.1468-1331.2007.01987.x, PubMed 17970735
  129. Harbo HF, Mørk S, Vedeler C, Myhr KM (2007)
    [Multiple sclerosis biobank established]
    Tidsskr Nor Laegeforen, 127 (17), 2276
    PubMed 17828328
  130. Smestad C, Brynedal B, Jonasdottir G, Lorentzen AR, Masterman T, Akesson E, Spurkland A, Lie BA, Palmgren J, Celius EG, Hillert J, Harbo HF (2007)
    The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients
    Eur J Neurol, 14 (8), 835-40
    DOI 10.1111/j.1468-1331.2007.01825.x, PubMed 17662002
  131. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallström E, Khademi M, Oturai A, Ryder LP, Saarela J, Harbo HF, Celius EG, Salter H, Olsson T, Hillert J (2007)
    Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis
    Nat Genet, 39 (9), 1108-13
    DOI 10.1038/ng2106, PubMed 17660816
  132. Berge T, Matre V, Brendeford EM, Saether T, Lüscher B, Gabrielsen OS (2007)
    Revisiting a selection of target genes for the hematopoietic transcription factor c-Myb using chromatin immunoprecipitation and c-Myb knockdown
    Blood Cells Mol Dis, 39 (3), 278-86
    DOI 10.1016/j.bcmd.2007.05.007, PubMed 17587615
  133. Datta P, Harbo HF, Ryder LP, Akesson E, Benedikz J, Celius EG, Andersen O, Myhr KM, Sandberg-Wollheim M, Hillert J, Svejgaard A, Sorensen PS, Spurkland A, Oturai A (2007)
    A follow-up study of Nordic multiple sclerosis candidate gene regions
    Mult Scler, 13 (5), 584-9
    DOI 10.1177/1352458506071790, PubMed 17548436
  134. Harbo HF, Spurkland A (2007)
    Genetics in multiple sclerosis: past and future perspectives
    Acta Neurol Scand Suppl, 187, 34-8
    DOI 10.1111/j.1600-0404.2007.00843.x, PubMed 17419826
  135. Harbo HF, Utsi E, Lorentzen AR, Kampman MT, Celius EG, Myhr KM, Lie BA, Mellgren SI, Thorsby E (2007)
    Low frequency of the disease-associated DRB1*15-DQB1*06 haplotype may contribute to the low prevalence of multiple sclerosis in Sami
    Tissue Antigens, 69 (4), 299-304
    DOI 10.1111/j.1399-0039.2007.00803.x, PubMed 17389012
  136. Hensiek AE, Seaman SR, Barcellos LF, Oturai A, Eraksoi M, Cocco E, Vecsei L, Stewart G, Dubois B, Bellman-Strobl J, Leone M, Andersen O, Bencsik K, Booth D, Celius EG, Harbo HF, Hauser SL, Heard R, Hillert J, Myhr KM, Marrosu MG, Oksenberg JR, Rajda C, Sawcer SJ, Sørensen PS et al. (2007)
    Familial effects on the clinical course of multiple sclerosis
    Neurology, 68 (5), 376-83
    DOI 10.1212/01.wnl.0000252822.53506.46, PubMed 17261686
  137. Lundmark F, Harbo HF, Celius EG, Saarela J, Datta P, Oturai A, Lindgren CM, Masterman T, Salter H, Hillert J (2006)
    Association analysis of the LAG3 and CD4 genes in multiple sclerosis in two independent populations
    J Neuroimmunol, 180 (1-2), 193-8
    DOI 10.1016/j.jneuroim.2006.08.009, PubMed 17020785
  138. Games Collaborative Group, Ban M, Booth D, Heard R, Stewart G, Goris A, Vandenbroeck K, Dubois B, Laaksonen M, Ilonen J, Alizadeh M, Edan G, Babron MC, Brassat D, Clanet M, Cournu-Rebeix I, Fontaine B, Semana G, Goedde R, Epplen J, Weber A, Infante-Duarte C, Zipp F, Rajda C, Bencsik K et al. (2006)
    Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans
    J Neuroimmunol, 179 (1-2), 108-16
    DOI 10.1016/j.jneuroim.2006.06.003, PubMed 16934875
  139. Harbo HF, Ekstrøm PO, Lorentzen AR, Sundvold-Gjerstad V, Celius EG, Sawcer S, Spurkland A (2006)
    Coding region polymorphisms in T cell signal transduction genes. Prevalence and association to development of multiple sclerosis
    J Neuroimmunol, 177 (1-2), 40-5
    DOI 10.1016/j.jneuroim.2006.04.021, PubMed 16764945
  140. Wiencke K, Boberg KM, Donaldson P, Harbo H, Ling V, Schrumpf E, Spurkland A (2006)
    No major effect of the CD28/CTLA4/ICOS gene region on susceptibility to primary sclerosing cholangitis
    Scand J Gastroenterol, 41 (5), 586-91
    DOI 10.1080/00365520500377870, PubMed 16638702
  141. Smerdel-Ramoya A, Finholt C, Lilleby V, Gilboe IM, Harbo HF, Maslinski S, Førre Ø, Thorsby E, Lie BA (2005)
    Systemic lupus erythematosus and the extended major histocompatibility complex--evidence for several predisposing loci
    Rheumatology (Oxford), 44 (11), 1368-73
    DOI 10.1093/rheumatology/kei015, PubMed 16174649
  142. Torkildsen O, Utsi E, Harbo HF, Mellgren SI, Vedeler CA, Myhr KM (2005)
    Ethnic variations of IL-10 polymorphisms in a Sami and Norwegian population
    Scand J Immunol, 62 (1), 71-4
    DOI 10.1111/j.1365-3083.2005.01635.x, PubMed 16091126
  143. Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A, Daly MJ, De Jager PL, Walsh E, Lander ES, Rioux JD, Hafler DA, Ivinson A, Rimmler J, Gregory SG, Schmidt S, Pericak-Vance MA, Akesson E, Hillert J, Datta P, Oturai A, Ryder LP, Harbo HF, Spurkland A, Myhr KM et al. (2005)
    A high-density screen for linkage in multiple sclerosis
    Am J Hum Genet, 77 (3), 454-67
    DOI 10.1086/444547, PubMed 16080120
  144. Lorentzen AR, Celius EG, Ekstrøm PO, Wiencke K, Lie BA, Myhr KM, Ling V, Thorsby E, Vartdal F, Spurkland A, Harbo HF (2005)
    Lack of association with the CD28/CTLA4/ICOS gene region among Norwegian multiple sclerosis patients
    J Neuroimmunol, 166 (1-2), 197-201
    DOI 10.1016/j.jneuroim.2005.06.002, PubMed 16005527
  145. Torkildsen O, Utsi E, Mellgren SI, Harbo HF, Vedeler CA, Myhr KM (2005)
    Ethnic variation of Fc gamma receptor polymorphism in Sami and Norwegian populations
    Immunology, 115 (3), 416-21
    DOI 10.1111/j.1365-2567.2005.02158.x, PubMed 15946259
  146. Harbo HF, Lie BA, Sawcer S, Celius EG, Dai KZ, Oturai A, Hillert J, Lorentzen AR, Laaksonen M, Myhr KM, Ryder LP, Fredrikson S, Nyland H, Sørensen PS, Sandberg-Wollheim M, Andersen O, Svejgaard A, Edland A, Mellgren SI, Compston A, Vartdal F, Spurkland A (2004)
    Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis
    Tissue Antigens, 63 (3), 237-47
    DOI 10.1111/j.0001-2815.2004.00173.x, PubMed 14989713
  147. Oturai AB, Ryder LP, Fredrikson S, Myhr KM, Celius EG, Harbo HF, Andersen O, Akesson E, Hillert J, Madsen HO, Nyland H, Spurkland A, Datta P, Svejgaard A, Sorensen PS (2004)
    Concordance for disease course and age of onset in Scandinavian multiple sclerosis coaffected sib pairs
    Mult Scler, 10 (1), 5-8
    DOI 10.1191/1352458504ms975oa, PubMed 14760946
  148. Myhr KM, Harbo HF (2003)
    [Multiple sclerosis--a disease with complex genetics]
    Tidsskr Nor Laegeforen, 123 (19), 2723-6
    PubMed 14600746
  149. Harbo HF, Datta P, Oturai A, Ryder LP, Sawcer S, Setakis E, Akesson E, Celius EG, Modin H, Sandberg-Wollheim M, Myhr KM, Andersen O, Hillert J, Sorensen PS, Svejgaard A, Compston A, Vartdal F, Spurkland A (2003)
    Two genome-wide linkage disequilibrium screens in Scandinavian multiple sclerosis patients
    J Neuroimmunol, 143 (1-2), 101-6
    DOI 10.1016/j.jneuroim.2003.08.021, PubMed 14575924
  150. Akesson E, Coraddu F, Marrosu MG, Massacesi L, Hensiek A, Harbo HF, Oturai A, Trojano M, Momigliano-Richiardi P, Cocco E, Murru R, Hillert J, Compston A, Sawcer S (2003)
    Refining the linkage analysis on chromosome 10 in 449 sib-pairs with multiple sclerosis
    J Neuroimmunol, 143 (1-2), 31-8
    DOI 10.1016/j.jneuroim.2003.08.008, PubMed 14575911
  151. Akesson E, Oturai A, Berg J, Fredrikson S, Andersen O, Harbo HF, Laaksonen M, Myhr KM, Nyland HI, Ryder LP, Sandberg-Wollheim M, Sorensen PS, Spurkland A, Svejgaard A, Holmans P, Compston A, Hillert J, Sawcer S (2002)
    A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis
    Genes Immun, 3 (5), 279-85
    DOI 10.1038/sj.gene.6363866, PubMed 12140746
  152. Isojärvi JI, Taubøll E, Pakarinen AJ, van Parys J, Rättyä J, Harbo HF, Dale PO, Fauser BC, Gjerstad L, Koivunen R, Knip M, Tapanainen JS (2001)
    Altered ovarian function and cardiovascular risk factors in valproate-treated women
    Am J Med, 111 (4), 290-6
    DOI 10.1016/s0002-9343(01)00806-3, PubMed 11566460
  153. Dai KZ, Harbo HF, Celius EG, Oturai A, Sørensen PS, Ryder LP, Datta P, Svejgaard A, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Myhr KM, Nyland H, Vartdal F, Spurkland A (2001)
    The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis
    Genes Immun, 2 (5), 263-8
    DOI 10.1038/sj.gene.6363774, PubMed 11528519
  154. Dai Y, Masterman T, Huang WX, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Oturai A, Ryder LP, Soelberg-Sørensen P, Svejgaard A, Hillert J (2001)
    Analysis of an interferon-gamma gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients
    Mult Scler, 7 (3), 157-63
    DOI 10.1177/135245850100700304, PubMed 11475438
  155. Larsen F, Oturai A, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Sawcer S, Fugger L, Sorensen PS, Svejgaard A (2000)
    Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q
    Genes Immun, 1 (7), 456-9
    DOI 10.1038/sj.gene.6363705, PubMed 11196677
  156. Celius EG, Harbo HF, Egeland T, Vartdal F, Vandvik B, Spurkiand A (2000)
    Sex and age at diagnosis are correlated with the HLA-DR2, DQ6 haplotype in multiple sclerosis
    J Neurol Sci, 178 (2), 132-5
    DOI 10.1016/s0022-510x(00)00389-0, PubMed 11018705
  157. Taubøll E, Isojärvi JI, Harbo HF, Pakarinen AJ, Gjerstad L (1999)
    Long-term valproate treatment induces changes in ovarian morphology and serum sex steroid hormone levels in female Wistar rats
    Seizure, 8 (8), 490-3
    DOI 10.1053/seiz.1999.0342, PubMed 10627413
  158. Harbo HF, Celius EG, Vartdal F, Spurkland A (1999)
    CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis
    Tissue Antigens, 53 (1), 106-10
    DOI 10.1034/j.1399-0039.1999.530112.x, PubMed 10082437
  159. Harbo HF (1996)
    [Brain abscess. A difficult diagnosis?]
    Tidsskr Nor Laegeforen, 116 (7), 866-8
    PubMed 8644101
  160. Bajwa SK, Nilsen KB, Erichsen EAS, Berg-Hansen P, Harbo HF (2018)
    A man in the 50s with dizziness, double vision and walking difficulties
    Tidsskr. Nor. Laegeforen., 138 (3), 253-256
  161. George MF, Briggs FBS, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedstrom A, Shen L, Bernstein A, Alfredsson L, Hiller J, Olsson T, Patsopoulos NA, De Jager PL, Oturai AB, Sondergaard HB, Sellebjerg F, Sorensen PS, Gomez R, Caillier SJ, Cree BAC, Oksenberg JR, Hauser SL et al. (2016)
    Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies
    Neurol.-Genet., 2 (4), eB7
    DOI 10.1212/NXG.00000000000000B7
  162. Akhmadeev K, Houssein A, Moussaoui S, Hogestol EA, Tutturen I, Harbo HF, Bos-Haugen SD, Graves J, Laplaud DA, Gourraud PA (2018)
    SVM-based Tool to Detect Patients with Multiple Sclerosis Using a Commercial EMG Sensor
    PR IEEE SEN ARRAY, 376-379
  163. Moen SM, Harbo HF, Sowa P, Celius EG, Nygaard GO, Beyer MK (2016)
    MRI- investigations in multiple sclerosis
    Tidsskr. Nor. Laegeforen., 136 (16), 1373-1376

 
Page visits: 81